Larimar Therapeutics, Inc.

Biotechnology • Healthcare • Bala Cynwyd, PA, United States • LRMR (NGM)

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

844 511 9056 Three Bala Plaza East, Bala Cynwyd, PA 19004, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Yahoo Finance

Yahoo Finance • Nov 14

Larimar Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewswire

GlobeNewswire • Nov 5

Mintz Advises on Larimar Therapeutics’ $69 Million Public Offering - Mintz

Mintz • Aug 5

Larimar Therapeutics exchanges common stock for preferred shares in agreement with Blue Owl - Investing.com

Investing.com • Dec 17

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

MarketBeat • Dec 23

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Larimar Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Larimar Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Larimar Therapeutics, Inc. have?

Larimar Therapeutics, Inc. has approximately 65 employees.

What industry is Larimar Therapeutics, Inc. in?

Larimar Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Larimar Therapeutics, Inc. a publicly traded company?

Yes, Larimar Therapeutics, Inc. is publicly traded under the ticker symbol LRMR on the NGM. The company has a market capitalization of approximately $0.34 billion.

Where is Larimar Therapeutics, Inc. headquartered?

Larimar Therapeutics, Inc. is headquartered in Bala Cynwyd, PA, United States at Three Bala Plaza East, Bala Cynwyd, PA 19004, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.